tim.hodson
Mon, 08/11/2025 – 14:52
Aug. 8, 2025 — Memorial Hermann-Texas Medical Center announced it will begin using a new FDA-approved ultrasound device to perform targeted, non-invasive treatment of liver tumors. The new treatment, called histotripsy, uses ultrasound energy to destroy liver tumors in a single outpatient procedure.
“Our team at Memorial Hermann is excited about the implications of this new technology for patients in the area,” said Dr. D. Ryan Hall, MD, general, …